The effect of scopolamine on fetal heart rate baseline variability

https://doi.org/10.1016/0002-9378(74)90156-2Get rights and content

Abstract

The effect on FHR baseline variability of intravenous scopolamine (0.43 mg.) administered alone and in combination with Demerol (50 mg.) and Largon (20 mg.) was evaluated. A decrease in baseline variability was found in nine of 19 patients given scopolamine (0.43 mg.). When scopolamine, Demerol, and Largon were infused simultaneously, a change in baseline variability was observed in nine of 12 patients. No change in variable or early deceleration FHR patterns was observed.

References (21)

  • H.A. Gabert et al.

    Am. J. Obstet. Gynecol

    (1973)
  • R.H. Paul

    Am. J. Obstet. Gynecol

    (1972)
  • L. Shenker

    Am. J. Obstet. Gynecol

    (1973)
  • R.C. Goodlin

    Am. J. Obstet. Gynecol

    (1971)
  • P. Renou et al.

    Am. J. Obstet. Gynecol

    (1969)
  • J. Bieniarz et al.

    Am. J. Obstet. Gynecol

    (1965)
  • B.G. Smiler et al.

    Am. J. Obstet. Gynecol

    (1973)
  • P.C.B. Davidsen

    Acta Obstet. Gynecol. Scand

    (1971)
  • B.S. Schifrin

    J. A. M. A

    (1972)
There are more references available in the full text version of this article.

Cited by (11)

  • Ethnicity and fetal heart rate variation

    1998, Obstetrics and Gynecology
  • Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk: Tenth edition

    2014, Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk: Tenth Edition
View all citing articles on Scopus
View full text